• 1. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
• 2. Evolving better nanoparticles: Genetic algorithms for optimising cluster geometries
  Dalton Trans., 2003, 4193-4207
• 3. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 4. Dissociative dynamics of O2 on Ag(110)?
  Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445
• 5. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198

Comprehensive Analysis of 5-Bromo-2-chloropyrimidine-4-carbonitrile (CAS 2092788-01-5): Properties, Applications, and Market Trends

5-Bromo-2-chloropyrimidine-4-carbonitrile (CAS 2092788-01-5) is a high-value heterocyclic compound widely recognized for its versatility in pharmaceutical intermediates and agrochemical synthesis. This pyrimidine derivative features a unique molecular structure combining bromine and chlorine substituents with a nitrile functional group, making it a critical building block in modern organic chemistry. Recent studies highlight its growing demand in drug discovery pipelines, particularly for kinase inhibitor development and anticancer agent research.

The compound's crystalline solid form and high purity grade (typically >98%) ensure optimal performance in cross-coupling reactions such as Suzuki-Miyaura and Buchwald-Hartwig animations. Industry reports indicate a 23% annual growth in applications for 5-Bromo-2-chloropyrimidine-4-carbonitrile within bioconjugation technologies, driven by advancements in proteolysis-targeting chimera (PROTAC) design. Its electron-withdrawing properties facilitate selective substitutions at the 4-position, a feature extensively utilized in material science for developing organic semiconductors.

Environmental considerations have spurred innovation in green synthesis methods for this compound. A 2023 Journal of Organic Chemistry study demonstrated a 40% reduction in solvent waste using microwave-assisted synthesis of 5-Bromo-2-chloropyrimidine-4-carbonitrile, addressing the pharmaceutical industry's focus on sustainable chemistry. The compound's stability under ambient storage conditions and compatibility with continuous flow reactors further enhance its industrial applicability.

Market analysis reveals increasing patent filings involving CAS 2092788-01-5, particularly in EGFR inhibitor formulations and herbicide safeners. The global pyrimidine derivatives market, valued at $1.2 billion in 2024, projects 5-Bromo-2-chloropyrimidine-4-carbonitrile as a key growth driver due to its role in developing next-generation crop protection agents. Analytical techniques like HPLC-MS and NMR spectroscopy confirm its structural integrity, with recent QSAR modeling studies predicting novel bioactivities.

Emerging applications in fluorescent probes and metal-organic frameworks (MOFs) showcase the compound's adaptability. Researchers at MIT recently incorporated 5-Bromo-2-chloropyrimidine-4-carbonitrile into luminescent sensors for heavy metal detection, leveraging its chelation properties. The compound's low hygroscopicity and thermal stability (decomposition >220°C) make it suitable for high-temperature reactions in materials engineering.

Supply chain data indicates Asia-Pacific as the dominant producer of CAS 2092788-01-5, with custom synthesis services accounting for 65% of transactions. Strict quality control protocols ensure batch-to-batch consistency, particularly for GMP-grade material used in clinical trial materials. The compound's regioselective reactivity continues to inspire novel scaffold hopping strategies in medicinal chemistry.

Future research directions focus on catalytic asymmetric synthesis of chiral pyrimidine derivatives using this compound as precursor. Its compatibility with photoredox catalysis and electrochemical transformations positions it as a strategic component in automated synthesis platforms. With 47 peer-reviewed publications referencing CAS 2092788-01-5 in 2023 alone, this multifunctional building block remains at the forefront of structure-activity relationship studies.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)